{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:44:36Z","timestamp":1771461876661,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:00:00Z","timestamp":1661904000000},"content-version":"vor","delay-in-days":242,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88881.507232\/2020-01"],"award-info":[{"award-number":["88881.507232\/2020-01"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.clinsp.2022.100105","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T07:01:37Z","timestamp":1662447697000},"page":"100105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Isolated specific IgA against respiratory viruses, Influenza or SARS-CoV-2, present in the saliva of a fraction of healthy and asymptomatic volunteers"],"prefix":"10.1016","volume":"77","author":[{"given":"Nahiara Esteves","family":"Zorgi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana R.","family":"Meireles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle Bruna Leal","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle Bastos","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edson L.","family":"Durigon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4697-4647","authenticated-orcid":false,"given":"Heitor Franco de","family":"Andrade Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinsp.2022.100105_bib0001","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/oxfordjournals.epirev.a036050","article-title":"The epidemiology of acute respiratory infections in children and adults: a global perspective","volume":"12","author":"Graham","year":"1990","journal-title":"Epidemiol Rev"},{"issue":"3","key":"10.1016\/j.clinsp.2022.100105_bib0002","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"10.1016\/j.clinsp.2022.100105_bib0003","doi-asserted-by":"crossref","first-page":"E372","DOI":"10.3390\/v12040372","article-title":"Virology, epidemiology, pathogenesis, and control of COVID-19","volume":"12","author":"Jin","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.clinsp.2022.100105_bib0004","unstructured":"WHO \u2013 https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/influenza-seasonal \u2013 Acesso em 24\/03\/2021."},{"key":"10.1016\/j.clinsp.2022.100105_bib0005","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.3389\/fimmu.2018.03103","article-title":"Immunogenicity of influenza vaccines: evidence for differential effect of secondary vaccination on humoral and cellular immunity","volume":"9","author":"Rosendahl Huber","year":"2019","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.clinsp.2022.100105_bib0006","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1172\/JCI63689","article-title":"Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms","volume":"122","author":"McKinstry","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinsp.2022.100105_bib0007","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.0105-2896.2005.00290.x","article-title":"Mucosal immunoglobulins","volume":"206","author":"Woof","year":"2005","journal-title":"Immunol Rev"},{"issue":"5617","key":"10.1016\/j.clinsp.2022.100105_bib0008","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.1083317","article-title":"Defective CD8 T cell memory following acute infection without CD4 T cell help","volume":"300","author":"Sun","year":"2003","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.clinsp.2022.100105_bib0009","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.coviro.2013.05.001","article-title":"Role of T cell immunity in recovery from influenza virus infection","volume":"3","author":"Sun","year":"2013","journal-title":"Curr Opin Virol"},{"issue":"10","key":"10.1016\/j.clinsp.2022.100105_bib0010","first-page":"3273","article-title":"Toward a broadly protective influenza vaccine","volume":"118","author":"Doherty","year":"2008","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.clinsp.2022.100105_bib0011","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4049\/jimmunol.2000413","article-title":"COVID-19 as an Acute Inflammatory Disease","volume":"205","author":"Manjili","year":"2020","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.clinsp.2022.100105_bib0012","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.25685","article-title":"Coronavirus infections and immune responses","volume":"92","author":"Li","year":"2020","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.clinsp.2022.100105_bib0013","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3390\/vaccines7040169","article-title":"Development of universal influenza vaccines targeting conserved viral proteins","volume":"7","author":"Jazayeri","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.clinsp.2022.100105_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111254","article-title":"Targets and strategies for vaccine development against SARS-CoV-2","volume":"137","author":"Malik","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.clinsp.2022.100105_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2019.103998","article-title":"Aging and influenza vaccine-induced immunity","volume":"348","author":"Dugan","year":"2020","journal-title":"Cell Immunol"},{"issue":"9","key":"10.1016\/j.clinsp.2022.100105_bib0016","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.cell.2021.03.013","article-title":"Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"issue":"10262","key":"10.1016\/j.clinsp.2022.100105_bib0017","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0140-6736(20)32137-1","article-title":"SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates","volume":"396","author":"Poland","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.clinsp.2022.100105_bib0018","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/irv.12664","article-title":"How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions","volume":"13","author":"Gianchecchi","year":"2019","journal-title":"Influenza Other Respir Viruses"},{"issue":"1","key":"10.1016\/j.clinsp.2022.100105_bib0019","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bjid.2019.11.005","article-title":"Andrade Junior HF. Measles, rubella, mumps and Toxoplasma gondii antibodies in saliva of vaccinated students of schools and universities in S\u00e3o Paulo City, Brazil","volume":"24","author":"Sampaio","year":"2020","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.clinsp.2022.100105_bib0020","doi-asserted-by":"crossref","first-page":"e2290","DOI":"10.6061\/clinics\/2020\/e2290","article-title":"Natural versus recombinant viral antigens in SARS-CoV-2 serology: challenges in optimizing laboratory diagnosis of COVID-19","volume":"75","author":"Meireles","year":"2020","journal-title":"Clinics (Sao Paulo, Brazil)"},{"issue":"6","key":"10.1016\/j.clinsp.2022.100105_bib0021","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1590\/S0036-46651990000600010","article-title":"Avalia\u00e7\u00e3o sorol\u00f3gica de imuniza\u00e7\u00e3o contra o sarampo com duas doses administradas aos 6 e 11 meses de idade: estudo prospectivo [Serological evaluation of immunization against measles with 2 doses administered at 6 and 11 months of age: a prospective study]","volume":"32","author":"Pannuti","year":"1990","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"1","key":"10.1016\/j.clinsp.2022.100105_bib0022","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3390\/biom4010235","article-title":"Refolding techniques for recovering biologically active recombinant proteins from inclusion bodies","volume":"4","author":"Yamaguchi","year":"2014","journal-title":"Biomolecules"},{"key":"10.1016\/j.clinsp.2022.100105_bib0023","article-title":"Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19)","volume":"11","author":"Flanagan","year":"2020","journal-title":"Vaccines. Front Immunol."},{"key":"10.1016\/j.clinsp.2022.100105_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104554","article-title":"Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection","volume":"152","author":"Khorramdelazad","year":"2021","journal-title":"Microb Pathog"},{"issue":"5","key":"10.1016\/j.clinsp.2022.100105_bib0025","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2217\/fvl-2016-0012","article-title":"Evaluating influenza vaccines: progress and perspectives","volume":"11","author":"Gianchecchi","year":"2016","journal-title":"Future Virol"},{"issue":"1","key":"10.1016\/j.clinsp.2022.100105_bib0026","doi-asserted-by":"crossref","first-page":"e02204","DOI":"10.1128\/JCM.02204-20","article-title":"COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva","volume":"59","author":"Pisanic","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"38","key":"10.1016\/j.clinsp.2022.100105_bib0027","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1016\/j.vaccine.2010.05.019","article-title":"Studies on the usefulness of intranasal inactivated influenza vaccines","volume":"28","author":"Tamura","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.clinsp.2022.100105_bib0028","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00731-21","article-title":"Saliva SARS-CoV-2 Antibody Prevalence in Children","volume":"9","author":"Keuning","year":"2021","journal-title":"Microbiol Spectr"},{"issue":"577","key":"10.1016\/j.clinsp.2022.100105_bib0029","doi-asserted-by":"crossref","first-page":"eabd2223","DOI":"10.1126\/scitranslmed.abd2223","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.clinsp.2022.100105_bib0030","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/eji.1830210602","article-title":"Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules","volume":"21","author":"Tamura","year":"1991","journal-title":"Eur J Immunol"},{"issue":"17","key":"10.1016\/j.clinsp.2022.100105_bib0031","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.vaccine.2014.02.009","article-title":"Intranasal vaccination with a replication-deficient influenza virus induces heterosubtypic neutralising mucosal IgA antibodies in humans","volume":"32","author":"Morokutti","year":"2014","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.clinsp.2022.100105_bib0032","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1080\/21645515.2018.1438791","article-title":"IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration","volume":"14","author":"Terauchi","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"10.1016\/j.clinsp.2022.100105_bib0033","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","volume":"17","author":"Tai","year":"2020","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10.1016\/j.clinsp.2022.100105_bib0034","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1038\/s41467-020-18450-4","article-title":"A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity","volume":"11","author":"Huang","year":"2020","journal-title":"Nat Commun"},{"issue":"15","key":"10.1016\/j.clinsp.2022.100105_bib0035","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/cid\/ciaa310","article-title":"Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)","volume":"71","author":"Guo","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinsp.2022.100105_bib0036","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/1743-422X-9-215","article-title":"Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain","volume":"9","author":"Shim","year":"2012","journal-title":"Virol J"},{"issue":"2","key":"10.1016\/j.clinsp.2022.100105_bib0037","doi-asserted-by":"crossref","first-page":"948","DOI":"10.4049\/jimmunol.180.2.948","volume":"180","author":"Du","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.clinsp.2022.100105_bib0038","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.cca.2020.09.018","article-title":"SARS-CoV-2 identification, and IgA antibodies in saliva: One sample two tests approach for diagnosis","volume":"510","author":"Aita","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"52","key":"10.1016\/j.clinsp.2022.100105_bib0039","doi-asserted-by":"crossref","first-page":"eabe5511","DOI":"10.1126\/sciimmunol.abe5511","article-title":"Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients","volume":"5","author":"Isho","year":"2020","journal-title":"Sci Immunol"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222033063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222033063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:50:24Z","timestamp":1761720624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222033063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":39,"alternative-id":["S1807593222033063"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2022.100105","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isolated specific IgA against respiratory viruses, Influenza or SARS-CoV-2, present in the saliva of a fraction of healthy and asymptomatic volunteers","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2022.100105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100105"}}